- Home
- SBCF vs TARS Comparison
SBCF vs TARS Comparison
Compare SBCF & TARS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SBCF | TARS |
|---|---|---|
| Founded | 1926 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.2B | 2.8B |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | SBCF | TARS |
|---|---|---|
| Price | $34.89 | $62.84 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 8 |
| Target Price | $32.00 | ★ $77.13 |
| AVG Volume (30 Days) | ★ 756.5K | 518.8K |
| Earning Date | 01-29-2026 | 02-24-2026 |
| Dividend Yield | ★ 2.19% | N/A |
| EPS Growth | ★ 10.56 | N/A |
| EPS | ★ 1.57 | N/A |
| Revenue | ★ $601,366,000.00 | $366,100,000.00 |
| Revenue This Year | $43.51 | $147.71 |
| Revenue Next Year | $5.52 | $53.74 |
| P/E Ratio | $22.05 | ★ N/A |
| Revenue Growth | 20.48 | ★ 182.44 |
| 52 Week Low | $21.36 | $38.51 |
| 52 Week High | $35.46 | $85.25 |
Technical Indicators
Market Signals| Indicator | SBCF | TARS |
|---|---|---|
| Relative Strength Index (RSI) | 63.35 | 29.94 |
| Support Level | $34.29 | $61.67 |
| Resistance Level | $35.24 | $67.45 |
| Average True Range (ATR) | 0.92 | 2.94 |
| MACD | 0.07 | -0.45 |
| Stochastic Oscillator | 79.92 | 12.06 |
Price Performance
Historical ComparisonAbout SBCF Seacoast Banking Corporation of Florida
Seacoast Banking Corp of Florida is a holding company for Seacoast National Bank. The company provides integrated financial services including commercial and consumer banking, wealth management, and mortgage and insurance services to customers across Florida, and through mobile and online banking solutions. In addition, it provides services such as treasury management, brokerage and credit facilities.
About TARS Tarsus Pharmaceuticals Inc.
Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.